- £80.22m
- £45.61m
- £35.17m
Brief: Venture Life Group Announces Acquisition Of FemiClear And CUROXEN
Acquisition of FemiClear and CUROXEN
Holding(s) in Company
UK's Venture Life FY results lifted by Power Brands, acquisitions; says 2026 rev ahead of 2025
Brief: Venture Life FY Revenue GBP 35.2 Million
Interim Results
Grant of Options and Director Dealing
Holding(s) in Company
PCA Dealing
Exercise of Share Options & Total Voting Rights
Trading Update
Exercise of Share Options & Total Voting Rights
Director/PDMR Shareholding
Exercise of Options, Director Dealings & TVR
Exercise of Share Options & Total Voting Rights
Holding(s) in Company
Holding(s) in Company
Brief: Venture Life Group Sells Non-Core Products For Up To £4.5M
Sale of Non-Core Products